Association of near-diploid DNA content and N-myc amplification in neuroblastomas
- 1 March 1989
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 7 (2) , 201-211
- https://doi.org/10.1007/bf01787024
Abstract
Seventeen neuroblastomas at different clinical stages were analysed for their N-myc copy number and flow cytometrically determined DNA content. Aneuploidy was found in 11 patients (65 per cent), whereas the remaining were near-diploid. N-myc amplification was found significantly (PP<0·05). Thus, flow cytometric analysis of DNA content together with N-myc gene dosage allowed us to distinguish two different subsets of neuroblastoma tumors: the first one aneuploid, with single-copy N-myc, usually observed in patients younger than 24 months with localized or IV-S clinical stages; the second one near-diploid, with frequent N-myc amplification, usually observed in patients older than 24 months with advanced clinical stages.This publication has 47 references indexed in Scilit:
- Prognostic Applications of DNA Flow Cytometry for Human Solid TumorsaAnnals of the New York Academy of Sciences, 1986
- Gene amplification in human neuroblastomas: Basic mechanisms and clinical implicationsCancer Genetics and Cytogenetics, 1986
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Clinical and biological significance of aneuploidy in human tumours.Journal of Clinical Pathology, 1984
- Convention on nomenclature for DNA cytometryCytometry, 1984
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- Chromosome localization in normal human cells and neuroblastomas of a gene related to c-mycNature, 1984
- The Clonal Evolution of Tumor Cell PopulationsScience, 1976
- DNA Content and DNA-Based Centromeric Index of the 24 Human ChromosomesScience, 1973
- SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSISThe Lancet, 1971